What Happened?
A number of stocks jumped in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed inflation rose by a modest 0.2% in July and 2.7% over the last year. This cooler-than-expected data prompted a significant market rally, with the S&P 500, Dow, and Nasdaq all climbing as investors grew more optimistic. The prevailing view is that easing inflation gives the central bank room to lower interest rates. Lower rates typically reduce borrowing costs for businesses and make stocks more attractive relative to bonds, contributing to widespread gains across sectors like healthcare.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks.
Among others, the following stocks were impacted:
- Research Tools & Consumables company Thermo Fisher (NYSE: TMO) jumped 3%. Is now the time to buy Thermo Fisher? Access our full analysis report here, it’s free.
- Medical Devices & Supplies - Cardiology, Neurology, Vascular company ICU Medical (NASDAQ: ICUI) jumped 3.4%. Is now the time to buy ICU Medical? Access our full analysis report here, it’s free.
- Surgical Equipment & Consumables - Diversified company CONMED (NYSE: CNMD) jumped 3.1%. Is now the time to buy CONMED? Access our full analysis report here, it’s free.
- Specialized Medical & Nursing Services company Pediatrix Medical Group (NYSE: MD) jumped 4.1%. Is now the time to buy Pediatrix Medical Group? Access our full analysis report here, it’s free.
- Drug Development Inputs & Services company IQVIA (NYSE: IQV) jumped 3%. Is now the time to buy IQVIA? Access our full analysis report here, it’s free.
Zooming In On Pediatrix Medical Group (MD)
Pediatrix Medical Group’s shares are somewhat volatile and have had 14 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The biggest move we wrote about over the last year was 4 months ago when the stock dropped 6.7% on the news that President Trump announced "reciprocal tariffs" on all US imports, set at a minimum rate of 10%. Markets reacted negatively to the announcement, reflecting deep concerns among investors about the broader economic implications. The tariffs were likely seen as a significant threat to global trade flows, with the potential to slow economic growth, drive up consumer prices, and spark retaliatory measures. Wedbush analyst Dan Ives captured the prevailing market anxiety, stating, "We would characterize this slate of tariffs as 'worse than the worst case scenario' the Street was fearing." His comment highlighted how the scope and severity of the tariffs far exceeded Wall Street's expectations, adding a new layer of uncertainty for businesses and investors.
Pediatrix Medical Group is up 13.1% since the beginning of the year, but at $14.74 per share, it is still trading 14.5% below its 52-week high of $17.23 from February 2025. Investors who bought $1,000 worth of Pediatrix Medical Group’s shares 5 years ago would now be looking at an investment worth $726.11.
Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.
